Belyntic, a Berlin, Germany-based developer of Peptide Easy Clean (PEC) purification technology, completed its €1.3m seed financing round.
The round was led by the Investitionsbank Berlin (IBB), with participation from High-Tech Gründerfonds (HTGF) and business angel Till Knorr.
The company intends to use the funds to develop new products and services to access clinical stage projects and regulated market segments as well as to grow internationally.
Led by Andreas Regnery, Belyntic is a spin-off from the Humboldt-University of Berlin that has developed proprietary “Peptide Easy Clean (PEC)” technology which provides actors along the pharmaceutical value chain from research and development to production with a protocol for parallel peptide purification.
PEC relies on an innovative catch-and-release purification between a novel linker molecule and a modified agarose filter material.